HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Detection of TDP-43 oligomers in frontotemporal lobar degeneration-TDP.

AbstractOBJECTIVE:
The proteinaceous inclusions in TDP-43 proteinopathies such as frontotemporal lobar degeneration (FTLD)-TDP are made of high-molecular-weight aggregates of TDP-43. These aggregates have not been classified as amyloids, as prior amyloid staining results were not conclusive. Here we used a specific TDP-43 amyloid oligomer antibody called TDP-O to determine the presence and abundance of TDP-43 oligomers among different subtypes of FTLD-TDP as well as in hippocampal sclerosis (HS), which represents a non-FTLD pathology with TDP-43 inclusions.
METHODS:
Postmortem tissue from the hippocampus and anterior orbital gyrus from 54 prospectively assessed and diagnosed subjects was used for immunostaining with TDP-O. Electron microscopy was used to assess the subcellular locations of TDP-O-decorated structures.
RESULTS:
TDP-43 inclusions staining with TDP-O were present in FTLD-TDP and were most conspicuous for FTLD-TDP type C, the subtype seen in most patients with semantic variant primary progressive aphasia. TDP-O immunoreactivity was absent in the hippocampus of HS patients despite abundant TDP-43 inclusions. Ultrastructurally, TDP-43 oligomers resided in granular or tubular structures, frequently in close proximity to, but not within, neuronal lysosomes.
INTERPRETATION:
TDP-43 forms amyloid oligomers in the human brain, which may cause neurotoxicity in a manner similar to other amyloid oligomers. Oligomer formation may contribute to the conformational heterogeneity of TDP-43 aggregates and mark the different properties of TDP-43 inclusions between FTLD-TDP and HS.
AuthorsPatricia F Kao, Yun-Ru Chen, Xiao-Bo Liu, Charles DeCarli, William W Seeley, Lee-Way Jin
JournalAnnals of neurology (Ann Neurol) Vol. 78 Issue 2 Pg. 211-21 (Aug 2015) ISSN: 1531-8249 [Electronic] United States
PMID25921485 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2015 American Neurological Association.
Chemical References
  • Amyloid
  • Biopolymers
  • DNA-Binding Proteins
  • TARDBP protein, human
Topics
  • Aged
  • Amyloid (metabolism)
  • Amyotrophic Lateral Sclerosis (metabolism)
  • Biopolymers (metabolism)
  • DNA-Binding Proteins (metabolism, ultrastructure)
  • Female
  • Frontotemporal Lobar Degeneration (metabolism)
  • Hippocampus (metabolism, pathology, ultrastructure)
  • Humans
  • Immunohistochemistry
  • Male
  • Microscopy, Electron
  • Middle Aged
  • Neurons (metabolism, ultrastructure)
  • Prefrontal Cortex (metabolism, ultrastructure)
  • Sclerosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: